Publications for Kelan L. Thomas kelan.thomas@tu.edu
Doroudgar, S., Chuang, H. M., Perry, P. J., Thomas, K. L., Bohnert, K., & Canedo, J. (2017). Driving performance comparing older versus younger drivers. Traffic Injury Prevention, 18(1), 41-46. doi:10.1080/15389588.2016.1194980
Brown, L. M., Thomas, K. L., & Shah, B. M. (2016). Vegetarianism and depression: An analysis of the National Health and Nutrition Examination Survey 2005-2012. Journal of Pharmacy Practice, 29(3), 327. doi:10.1177/0897190016645328
Dopheide, J., Bostwick, J., Goldstone, L., Gable, K., Thomas, K. L., Cates, M., . . . Bainbridge, J. (2016). A 2015 survey of pharmacy curriculum in psychiatry and neurology in the United States. Journal of Pharmacy Practice, 29(3), 274. doi:10.1177/0897190016645328
Dopheide, J., Goldstone, L., Bostwick, J., Thomas, K. L., Caballero, J., Smith, T., . . . Bainbridge, J. (2016). A curriculum survey of CPNP members with BCPP credentials and academic affiliations. Journal of Pharmacy Practice, 29(3), 274. doi:10.1177/0897190016645328
Maroney, M. E., Liu, M. T., Smith, T., & Thomas, K. L. (2016). Lithium. In S. D. Ray (Ed.), Side effects of drugs annual (Vol. 38, pp. 21-28). Cambridge, MA: Elsevier. doi:10.1016/bs.seda.2016.07.014
Nguyen, L., Thomas, K. L., Lucke-Wold, B. P., Cavendish, J. Z., Crowe, M. S., & Matsumoto, R. R. (2016). Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders. Pharmacology & Therapeutics, 159, 1-22. doi:10.1016/j.pharmthera.2016.01.016
Ray, S. D., Thomas, K. L., & Kisor, D. F. (2016). ADRs, ADEs and SEDs: A bird's eye view. In S. D. Ray (Ed.), Side effects of drugs annual (Vol. 38, pp. xxvii-xl). Cambridge, MA: Elsevier. doi:10.1016/S0378-6080(16)30060-5
Thomas, K. L., Canedo, J., Perry, P. J., Doroudgar, S., Lopes, I., Chuang, H. M., & Bohnert, K. (2016). Effects of valerian on subjective sedation, field sobriety testing and driving simulator performance. Accident Analysis & Prevention, 92, 240-244. This material can be found here.
Thomas, K. L., La, A. Q., Punia, S., Doroudgar, S., & Perry, P. J. (2016). Valproic acid-induced hyperammonemia and minimal hepatic encephalopathy prevalence among psychiatric inpatients. Annals of Clinical Psychiatry, 28(1), 37-42. This material can be found here.
Perry, P. J., Fredriksen, K., Chew, S., Ip, E. J., Lopes, I., Doroudgar, S., & Thomas, K. L. (2015). The effects of dextromethorphan on driving performance and the Standardized Field Sobriety Test. Journal of Forensic Sciences, 60(5), 1258–1262. doi:10.1111/1556-4029.12833
Thomas, K. L., Jiang, Y., & McCombs, J. S. (2015). Clozapine revisited: Impact of clozapine vs olanzapine on health care use by schizophrenia patients on Medicaid. Annals of Clinical Psychiatry, 27(1), e1-e10. This material can be found here.
English, B. A., Thomas, K. L., Johnstone, J., Bazih, A., Gertsik, L., & Ereshefsky, L. (2014). Use of translational pharmacodynamic biomarkers in early-phase clinical studies for schizophrenia. Biomarkers in Medicine, 8(1), 29-49. doi:10.2217/bmm.13.135
English, B. A., Ereshefsky, L., Thomas, K. L., & Jhee, S. (2013). Improving transition of investigational medicines in Alzheimer's disease from phase 1 to phase 2. Journal for Clinical Studies, 5(1), 52-59.
